13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Effects of acute and chronic systemic methamphetamine on respiratory, cardiovascular and metabolic function, and cardiorespiratory reflexes : Physiological systems altered by acute and chronic methamphetamine

      , , ,
      The Journal of Physiology
      Wiley-Blackwell

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          <div class="section"> <a class="named-anchor" id="tjp6975-sec-0010"> <!-- named anchor --> </a> <h5 class="section-title" id="d11632331e218">Key points</h5> <p id="d11632331e220"> <div class="list"> <a class="named-anchor" id="tjp6975-list-0001"> <!-- named anchor --> </a> <ul class="so-custom-list"> <li id="d11632331e223"> <div class="so-custom-list-content so-ol"> <p class="first" id="d11632331e224">Methamphetamine (METH) abuse is escalating worldwide, with the most common cause of death resulting from cardiovascular failure and hyperthermia; however, the underlying physiological mechanisms are poorly understood. </p> </div> </li> <li id="d11632331e226"> <div class="so-custom-list-content so-ol"> <p class="first" id="d11632331e227">Systemic administration of METH in anaesthetised rats reduced the effectiveness of some protective cardiorespiratory reflexes, increased central respiratory activity independently of metabolic function, and increased heart rate, metabolism and respiration in a pattern indicating that non‐shivering thermogenesis contributes to the well‐described hyperthermia. </p> </div> </li> <li id="d11632331e229"> <div class="so-custom-list-content so-ol"> <p class="first" id="d11632331e230">In animals that showed METH‐induced behavioural sensitisation following chronic METH treatment, no changes were evident in baseline cardiovascular, respiratory and metabolic measures and the METH‐evoked effects in these parameters were similar to those seen in saline‐treated or drug naïve animals. </p> </div> </li> <li id="d11632331e232"> <div class="so-custom-list-content so-ol"> <p class="first" id="d11632331e233">Physiological effects evoked by METH were retained but were neither facilitated nor depressed following chronic treatment with METH. </p> </div> </li> <li id="d11632331e235"> <div class="so-custom-list-content so-ol"> <p class="first" id="d11632331e236">These data highlight and identify potential mechanisms for targeted intervention in patients vulnerable to METH overdose. </p> </div> </li> </ul> </div> </p> </div><div class="section"> <a class="named-anchor" id="tjp6975-sec-0020"> <!-- named anchor --> </a> <h5 class="section-title" id="d11632331e240">Abstract</h5> <p id="d11632331e242">Methamphetamine (METH) is known to promote cardiovascular failure or life‐threatening hyperthermia; however, there is still limited understanding of the mechanisms responsible for evoking the physiological changes. In this study, we systematically determined the effects on both autonomic and respiratory outflows, as well as reflex function, following acute and repeated administration of METH, which enhances behavioural responses. Arterial pressure, heart rate, phrenic nerve discharge amplitude and frequency, lumbar and splanchnic sympathetic nerve discharge, interscapular brown adipose tissue and core temperatures, and expired CO <sub>2</sub> were measured in urethane‐anaesthetised male Sprague‐Dawley rats. Novel findings include potent increases in central inspiratory drive and frequency that are not dependent on METH‐evoked increases in expired CO <sub>2</sub> levels. Increases in non‐shivering thermogenesis correlate with well‐described increases in body temperature and heart rate. Unexpectedly, METH evoked minor effects on both sympathetic outflows and mean arterial pressure. METH modified cardiorespiratory reflex function in response to hypoxia, hypercapnia and baroreceptor unloading. Chronically METH‐treated rats failed to exhibit changes in baseline sympathetic, cardiovascular, respiratory and metabolic parameters. The tonic and reflex cardiovascular, respiratory and metabolic responses to METH challenge were similar to those seen in saline‐treated and drug naive animals. Overall, these findings describe independent and compound associations between physiological systems evoked by METH and serve to highlight that a single dose of METH can significantly impact basic homeostatic systems and protective functions. These effects of METH persist even following chronic METH treatment. </p> </div><p id="d11632331e253"> <div class="list"> <a class="named-anchor" id="tjp6975-list-0002"> <!-- named anchor --> </a> <ul class="so-custom-list"> <li id="d11632331e256"> <div class="so-custom-list-content so-ol"> <p class="first" id="d11632331e257">Methamphetamine (METH) abuse is escalating worldwide, with the most common cause of death resulting from cardiovascular failure and hyperthermia; however, the underlying physiological mechanisms are poorly understood. </p> </div> </li> <li id="d11632331e259"> <div class="so-custom-list-content so-ol"> <p class="first" id="d11632331e260">Systemic administration of METH in anaesthetised rats reduced the effectiveness of some protective cardiorespiratory reflexes, increased central respiratory activity independently of metabolic function, and increased heart rate, metabolism and respiration in a pattern indicating that non‐shivering thermogenesis contributes to the well‐described hyperthermia. </p> </div> </li> <li id="d11632331e262"> <div class="so-custom-list-content so-ol"> <p class="first" id="d11632331e263">In animals that showed METH‐induced behavioural sensitisation following chronic METH treatment, no changes were evident in baseline cardiovascular, respiratory and metabolic measures and the METH‐evoked effects in these parameters were similar to those seen in saline‐treated or drug naïve animals. </p> </div> </li> <li id="d11632331e265"> <div class="so-custom-list-content so-ol"> <p class="first" id="d11632331e266">Physiological effects evoked by METH were retained but were neither facilitated nor depressed following chronic treatment with METH. </p> </div> </li> <li id="d11632331e268"> <div class="so-custom-list-content so-ol"> <p class="first" id="d11632331e269">These data highlight and identify potential mechanisms for targeted intervention in patients vulnerable to METH overdose. </p> </div> </li> </ul> </div> </p>

          Related collections

          Most cited references51

          • Record: found
          • Abstract: found
          • Article: not found

          A review of the clinical pharmacology of methamphetamine.

          To examine the literature regarding clinical pharmacokinetics, direct effects and adverse clinical outcomes associated with methamphetamine use. Relevant literature was identified through a PubMed search. Additional literature was obtained from relevant books and monographs. The mean elimination half-life for methamphetamine is approximately 10 hours, with considerable inter-individual variability in pharmacokinetics. Direct effects at low-to-moderate methamphetamine doses (5-30 mg) include arousal, positive mood, cardiac stimulation and acute improvement in cognitive domains such as attention and psychomotor coordination. At higher doses used typically by illicit users (> or =50 mg), methamphetamine can produce psychosis. Its hypertensive effect can produce a number of acute and chronic cardiovascular complications. Repeated use may induce neurotoxicity, associated with prolonged psychiatric symptoms, cognitive impairment and an increased risk of developing Parkinson's disease. Abrupt cessation of repeated methamphetamine use leads to a withdrawal syndrome consisting of depressed mood, anxiety and sleep disturbance. Acute withdrawal lasts typically for 7-10 days, and residual symptoms associated with neurotoxicity may persist for several months.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Methamphetamine toxicity and messengers of death.

            Methamphetamine (METH) is an illicit psychostimulant that is widely abused in the world. Several lines of evidence suggest that chronic METH abuse leads to neurodegenerative changes in the human brain. These include damage to dopamine and serotonin axons, loss of gray matter accompanied by hypertrophy of the white matter and microgliosis in different brain areas. In the present review, we summarize data on the animal models of METH neurotoxicity which include degeneration of monoaminergic terminals and neuronal apoptosis. In addition, we discuss molecular and cellular bases of METH-induced neuropathologies. The accumulated evidence indicates that multiple events, including oxidative stress, excitotoxicity, hyperthermia, neuroinflammatory responses, mitochondrial dysfunction, and endoplasmic reticulum stress converge to mediate METH-induced terminal degeneration and neuronal apoptosis. When taken together, these findings suggest that pharmacological strategies geared towards the prevention and treatment of the deleterious effects of this drug will need to attack the various pathways that form the substrates of METH toxicity.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Toxicity of amphetamines: an update.

              Amphetamines represent a class of psychotropic compounds, widely abused for their stimulant, euphoric, anorectic, and, in some cases, emphathogenic, entactogenic, and hallucinogenic properties. These compounds derive from the β-phenylethylamine core structure and are kinetically and dynamically characterized by easily crossing the blood-brain barrier, to resist brain biotransformation and to release monoamine neurotransmitters from nerve endings. Although amphetamines are widely acknowledged as synthetic drugs, of which amphetamine, methamphetamine, and 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) are well-known examples, humans have used natural amphetamines for several millenniums, through the consumption of amphetamines produced in plants, namely cathinone (khat), obtained from the plant Catha edulis and ephedrine, obtained from various plants in the genus Ephedra. More recently, a wave of new amphetamines has emerged in the market, mainly constituted of cathinone derivatives, including mephedrone, methylone, methedrone, and buthylone, among others. Although intoxications by amphetamines continue to be common causes of emergency department and hospital admissions, it is frequent to find the sophism that amphetamine derivatives, namely those appearing more recently, are relatively safe. However, human intoxications by these drugs are increasingly being reported, with similar patterns compared to those previously seen with classical amphetamines. That is not surprising, considering the similar structures and mechanisms of action among the different amphetamines, conferring similar toxicokinetic and toxicological profiles to these compounds. The aim of the present review is to give an insight into the pharmacokinetics, general mechanisms of biological and toxicological actions, and the main target organs for the toxicity of amphetamines. Although there is still scarce knowledge from novel amphetamines to draw mechanistic insights, the long-studied classical amphetamines-amphetamine itself, as well as methamphetamine and MDMA, provide plenty of data that may be useful to predict toxicological outcome to improvident abusers and are for that reason the main focus of this review.
                Bookmark

                Author and article information

                Journal
                The Journal of Physiology
                J Physiol
                Wiley-Blackwell
                00223751
                February 01 2016
                February 01 2016
                : 594
                : 3
                : 763-780
                Article
                10.1113/JP271257
                5341715
                26584821
                64729abf-238e-498d-941c-fb68aed517d7
                © 2016

                http://doi.wiley.com/10.1002/tdm_license_1.1

                History

                Comments

                Comment on this article